Prof. Dr. Gregor Hutter

Martins, Tomás A., Kaymak, Deniz, Tatari, Nazanin, Gerster, Fiona, Hogan, Sabrina, Ritz, Marie-Françoise, Sabatino, Valerio, Wieboldt, Ronja, Bartoszek, Ewelina M., McDaid, Marta, Gerber, Alexandra, Buck, Alicia, Beshirova, Aisha, Heider, Anja, Shekarian, Tala, Mohamed, Hayget, Etter, Manina M., Schmassmann, Philip, Abel, Ines, et al. (2024). Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker [Journal-article]. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-54129-w

Hench, J., Hultschig, C., Bratic Hench, I., Sadasivan, H., Yaldizli, Ö., Hutter, G., Dirnhofer, S., Tzankov, A., & Frank, S. (2024). Rapid brain lymphoma diagnostics through nanopore sequencing of cytology-negative cerebrospinal fluid. Acta Neuropathologica, 148. https://doi.org/10.1007/s00401-024-02793-z

Mironov, Aleksei, Franchitti, Lorenzo, Ghosh, Shreemoyee, Ritz, Marie-Francoise, Hutter, Gregor, De Bortoli, Michele, & Zavolan, Mihaela. (2024). Leveraging multi-omics data to infer regulators of mRNA 3’ end processing in glioblastoma. Frontiers in Molecular Biosciences, 11. https://doi.org/10.3389/fmolb.2024.1363933

Theocharides, Alexandre P. A., Hutter, Gregor, & Saito, Yasuyuki. (2024). Editorial: The therapeutic inhibition of macrophage checkpoints. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1418281

Schmassmann, Philip, Roux, Julien, Dettling, Steffen, Hogan, Sabrina, Shekarian, Tala, Martins, Tomás A, Ritz, Marie-Françoise, Herter, Sylvia, Bacac, Marina, & Hutter, Gregor. (2023). Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation [Journal-article]. eLife, 12. https://doi.org/10.7554/elife.92678.2

Starck, L., Sarem, M., Heimrich, B., Sawarkar, R., Ritz, M.-F., Hutter, G., & Shastri, V. P. (2023, August 2). Biophysical basis for the induction of glioblastoma-like phenotype in astrocytes [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.07.31.551259

Borisov, Vladislav, Gili Sole, Laia, Reid, Gregory, Milan, Giulia, Hutter, Gregor, Grapow, Martin, Eckstein, Friedrich Stefan, Isu, Giuseppe, & Marsano, Anna. (2023). Upscaled Skeletal Muscle Engineered Tissue with In Vivo Vascularization and Innervation Potential. Bioengineering, 10. https://doi.org/10.3390/bioengineering10070800

Leu, S., Hutter, G., & Boulay, J.-L. (2023). Proteome-based insights for IDH-mutant glioma classification. Cell Reports Medicine, 4. https://doi.org/10.1016/j.xcrm.2022.100909

Saemann, Attill, Schulze-Zachau, Victor, Guzman, Raphael, & Hutter, Gregor. (2023). Delayed headache 11 years after a pub fight: an unusual spontaneous intracerebral hemorrhage succeeding a temporal glass shard injury. Illustrative case. Journal of Neurosurgery: Case Lessons, 6(10). https://doi.org/10.3171/case23364

Schmassmann, P., Roux, J., Buck, A., Tatari, N., Hogan, S., Wang, J., Mantuano, N. R., Wieboldt, R., Lee, S., Snijder, B., Kaymak, D., Martins, T. A., Ritz, M.-F., Shekarian, T., McDaid, M., Weller, M., Weiss, T., Läubli, H., & Hutter, G. (2023). Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. Science Translational Medicine, 15. https://doi.org/10.1126/scitranslmed.adf5302

Schmassmann, Philip, Roux, Julien, Dettling, Steffen, Hogan, Sabrina, Shekarian, Tala, Martins, Tomás A., Ritz, Marie-Françoise, Herter, Sylvia, Bacac, Marina, & Hutter, Gregor. (2023). Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. eLife, 12. https://doi.org/10.7554/elife.92678

Uzun, Sarp, Zinner, Carl P., Beenen, Amke C., Alborelli, Ilaria, Bartoszek, Ewelina M., Bartoszek, Ewelina M., Yeung, Jason, Calgua, Byron, Reinscheid, Matthias, Bronsert, Peter, Stalder, Anna K., Haslbauer, Jasmin D., Vosbeck, Juerg, Mazzucchelli, Luca, Hoffmann, Tobias, Terracciano, Luigi M., Hutter, Gregor, Manz, Michael, Panne, Isabelle, et al. (2023). Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics. Journal of Hepatology, 79, 666–676. https://doi.org/10.1016/j.jhep.2023.05.020

Schmassmann, P., Roux, J., Buck, A., Tatari, N., Hogan, S., Wang, J., Lee, S., Snijder, B., Martins, T. A., Ritz, M.-F., Shekarian, T., Kaymak, D., McDaid, M., Weller, M., Weiss, T., Läubli, H., & Hutter, G. (2022, November 7). The Siglec-sialic acid-axis is a target for innate immunotherapy of glioblastoma [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.11.07.515406

Ho JQ, Sepand MR, Bigdelou B, Shekarian T, Esfandyarpour R, Chauhan P, Serpooshan V, Beura LK, Hutter G, & Zanganeh S. (2022). The immune response to COVID-19: Does sex matter? Immunology, 166(4), 429–443. https://doi.org/10.1111/imm.13487

Shekarian T, Zinner CP, Bartoszek EM, Duchemin W, Wachnowicz AT, Hogan S, Etter MM, Flammer J, Paganetti C, Martins TA, Schmassmann P, Zanganeh S, Le Goff F, Muraro MG, Ritz MF, Phillips D, Bhate SS, Barlow GL, Nolan GP, et al. (2022). Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery. Science Advances, 8(26), eabn9440. https://doi.org/10.1126/sciadv.abn9440

Schmassmann, P., Roux, J., Dettling, S., Hogan, S., Shekarian, T., Martins, T. A., Ritz, M.-F., Herter, S., Bacac, M., & Hutter, G. (2022, June 19). Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.06.17.496574

Etter, M. M., A. Martins, T., Kulsvehagen, L., Pössnecker, E., Duchemin, W., Hogan, S., Sanabria-Diaz, G., Müller, J., Chiappini, A., Rychen, J., Eberhard, N., Melie-Garcia, L., Keller, E., Jelcic, I., Pargger, H., Siegemund, M., Kuhle, J., Oechtering, J., Eich, C., et al. (2022, March 2). Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: a prospective cross-sectional study [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.02.18.22271039

Sanabria-Diaz, G., Etter, M. M., Melie-Garcia, L., Lieb, J., Psychogios, M.-N., Hutter, G., & Granziera, C. (2022, February 15). Brain cortical changes are related to inflammatory biomarkers in hospitalized SARS-CoV-2 patients with neurological symptoms [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.02.13.22270662

Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, Sullivan I, Chauhan P, Etter M, Shekarian T, Liang O, Hutter G, Esfandiarpour R, & Zanganeh S. (2022). COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Frontiers in Immunology, 13, 890517. https://doi.org/10.3389/fimmu.2022.890517

Etter, Manina M., Martins, Tomás A., Kulsvehagen, Laila, Pössnecker, Elisabeth, Duchemin, Wandrille, Hogan, Sabrina, Sanabria-Diaz, Gretel, Müller, Jannis, Chiappini, Alessio, Rychen, Jonathan, Eberhard, Noëmi, Guzman, Raphael, Mariani, Luigi, Melie-Garcia, Lester, Keller, Emanuela, Jelcic, Ilijas, Pargger, Hans, Siegemund, Martin, Kuhle, Jens, et al. (2022). Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nature Communications, 13. https://doi.org/10.1038/s41467-022-34068-0

Kasenda, B., König, D., Manni, M., Ritschard, R., Duthaler, U., Bartoszek, E., Bärenwaldt, A., Deuster, S., Hutter, G., Cordier, D., Mariani, L., Hench, J., Frank, S., Krähenbühl, S., Zippelius, A., Rochlitz, C., Mamot, C., Wicki, A., & Läubli, H. (2022). Targeting immunoliposomes to EGFR-positive glioblastoma. ESMO Open, 7. https://doi.org/10.1016/j.esmoop.2021.100365

Li, Aijun, Muenst, Simone, Hoffman, Julius, Starck, Laurent, Sarem, Melika, Fischer, Andreas, Hutter, Gregor, & Shastri, V. Prasad. (2022). Mesenchymal-endothelial nexus in breast cancer spheroids induces vasculogenesis and local invasion in a CAM model. Communications Biology, 5. https://doi.org/10.1038/s42003-022-04236-5

Parmigiani, Elena, Ivanek, Robert, Rolando, Chiara, Hafen, Katrin, Turchinovich, Gleb, Lehmann, Frank Michael, Gerber, Alexandra, Brkic, Sime, Frank, Stephan, Meyer, Sara C., Wakimoto, Hiroaki, Günel, Murat, Louvi, Angeliki, Mariani, Luigi, Finke, Daniela, Holländer, Georg, Hutter, Gregor, Tussiwand, Roxane, Taylor, Verdon, & Giachino, Claudio. (2022). Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells. Developmental Cell, 57, 1847–1865. https://doi.org/10.1016/j.devcel.2022.06.006

Rychen, Jonathan, Saemann, Attill, Gehweiler, Julian E., Roethlisberger, Michel, Soleman, Jehuda, Hutter, Gregor, Müller-Gerbl, Magdalena, Mariani, Luigi, & Guzman, Raphael. (2022). The sylvian keyhole approach for surgical clipping of middle cerebral artery aneurysms: Technical nuance to the minipterional craniotomy. Frontiers in Surgery, 9. https://doi.org/10.3389/fsurg.2022.1078735

Sanabria-Diaz, Gretel, Etter, Manina Maja, Melie-Garcia, Lester, Lieb, Johanna M., Psychogios, Marios-Nikos, Hutter, Gregor, & Granziera, Cristina. (2022). Brain cortical alterations in COVID-19 patients with neurological symptoms. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.992165

Brkic S, Stivala S, Santopolo A, Szybinski J, Jungius S, Passweg JR, Tsakiris D, Dirnhofer S, Hutter G, Leonards K, Lischer HEL, Dettmer MS, Neel BG, Levine RL, & Meyer SC. (2021). Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia, 35(10), 2875–2884. https://doi.org/10.1038/s41375-021-01391-2

Hofer S, Keller K, Imbach L., Roelcke U, Hutter G., Hundsberger T., Hertler C., Le Rhun E., Vasella F., Cordier D, Neidert M., Hottinger A., Migliorini D., Pflugshaupt T., Eggenberger N., Baumert B., Laubli H., Gramatzki D., Reinert M, et al. (2021). Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss Medical Weekly, 151, w20501. https://doi.org/10.4414/smw.2021.20501

Pantelyushin S., Ranninger E., Guerrera D., Hutter G., Maake C., Markkanen E., Bettschart-Wolfensberger R., Bley C.R., Laubli H., & Vom Berg J. (2021). Cross-reactivity and functionality of approved human immune checkpoint blockers in dogs. Cancers, 13(4), 1–18. https://doi.org/10.3390/cancers13040785

Etter MM, Bonati L, Tsogkas I, Hutter G, Blackham K, Guzman R, & Psychogios MN. (2021). Treatment and Postinterventional Management of a Fusiform Intracranial Aneurysm in a Professional Soccer Player: A Case Report. 12, 732640. https://doi.org/10.3389/fneur.2021.732640

Saleh C., Seidl U., Hutter G., & Hund-Georgiadis M. (2021). The need for neuroimaging in first manifestations of psychiatric symptoms. Surgical Neurology International, 12. https://doi.org/10.25259/sni_754_2021

Martins T.A., Schmassmann P., Shekarian T., Boulay JL, Ritz M.-F., Zanganeh S., vom Berg J., & Hutter G. (2020). Microglia-Centered Combinatorial Strategies Against Glioblastoma. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.571951

Zanganeh, S., Georgala, P., Corbo, C., Arabi, L., Ho, J. Q., Javdani, N., Sepand, M. R., Cruickshank, K., Campesato, L. F., Weng, C.-H., Hemayat, S., Andreou, C., Alvim, R., Hutter, G., Rafat, M., & Mahmoudi, M. (2019). Immunoengineering in glioblastoma imaging and therapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 11(6). https://doi.org/10.1002/wnan.1575

Shekarian T, Sivado E, Jallas AC, Depil S, Kielbassa J, Janoueix-Lerosey I, Hutter G, Goutagny N, Bergeron C, Viari A, Valsesia-Wittmann S, Caux C, & Marabelle A. (2019). Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade. Science Translational Medicine, 11(515). https://doi.org/10.1126/scitranslmed.aat5025

Hutter G, Theruvath J, Graef CM, Zhang M, Schoen MK, Manz EM, Bennett ML, Olson A, Azad TD, Sinha R, Chan C, Assad Kahn S, Gholamin S, Wilson C, Grant G, He J, Weissman IL, Mitra SS, & Cheshier SH. (2019). Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America, 116(3), 997–1006. https://doi.org/10.1073/pnas.1721434116

Buser, Dominik P., Ritz, Marie-Françoise, Moes, Suzette, Tostado, Cristobal, Frank, Stephan, Spiess, Martin, Mariani, Luigi, Jenö, Paul, Boulay, Jean-Louis, & Hutter, Gregor. (2019). Quantitative proteomics reveals reduction of endocytic machinery components in gliomas. EBioMedicine, 46, 32–41. https://doi.org/10.1016/j.ebiom.2019.07.039

Kahn S.A., Wang X., Nitta R.T., Gholamin S., Theruvath J., Hutter G., Azad T.D., Wadi L., Bolin S., Ramaswamy V., Esparza R., Liu K.-W., Edwards M., Swartling F.J., Sahoo D., Li G., Wechsler-Reya R.J., Reimand J., Cho Y.-J., et al. (2018). Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-06564-9

Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, Li G, Wechsler-Reya RJ, Reimand J, Cho YJ, et al. (2018). Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. (Patent No. 1). 9(1), Article 1. https://doi.org/10.1038/s41467-018-07182-1

Gregor Hutter. (2017, November 16). A POTENT MICROGLIAL RESPONSE TO BLOCKING THE CD47-SIRPα ANTI-PHAGOCYTIC AXIS OVERCOMES DEFICIENT MACROPHAGE RECRUITMENT DURING ANTI-CD47 IMMUNOTHERAPY AGAINST GLIOBLASTOMA. SNO Meeting. https://doi.org/10.1093/neuonc/nox168.994

Zanganeh S, Spitler R, Hutter G, Ho JQ, Pauliah M, & Mahmoudi M. (2017). Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy. Immunotherapy, 9(10), 819–835. https://doi.org/10.2217/imt-2017-0041

Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D, Ring AM, Connolly AJ, & Weissman IL. (2017). PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature, 545(7655), 495–499. https://doi.org/10.1038/nature22396

Hutter,Gregor. (2017, April 1). Induction of differential macrophage and microglial glioblastoma phagocytosis by anti CD47 treatment - implication of tumor subtypes. WFNOS Meeting. https://doi.org/10.1093/neuonc/nox036.003

Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, Storm TA, Schubert S, Hutter G, Narayanan C, et al. (2017). Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science translational medicine, 9(381). https://doi.org/10.1126/scitranslmed.aaf2968

Hutter G., Sailer M, Azad T.D., von Bueren A.O., Nollau P., Frank S., Tostado C., Sarvepalli D., Ghosh A, Ritz M.-F., Boulay J.-L., & Mariani L. (2017). Reverse phase protein arrays enable glioblastoma molecular subtyping. Journal of Neuro-Oncology, 131(3), 437–448. https://doi.org/10.1007/s11060-016-2316-5

Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A, Pajarinen JS, Nejadnik H, Goodman S, Moseley M, Coussens LM, & Daldrup-Link HE. (2016). Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nature nanotechnology, 11(11), 986–994. https://doi.org/10.1038/nnano.2016.168

Mitra S.S., He J.Q., Esparza R., Hutter G., Cheshier S.H., & Weissman I. (2016). Introduction: Cancer Stem Cells (pp. 3–24). https://doi.org/10.1016/b978-0-12-803892-5.00001-2

Sailer, Martin H., Sarvepalli, Durga, Bregere, Catherine, Fisch, Urs, Guentchev, Marin, Weller, Michael, Guzman, Raphael, Bettler, Bernhard, Ghosh, Arkasubhra, & Hutter, Gregor. (2016). An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery. Jove-Journal of Visualized Experiments, 114, 54018. https://doi.org/10.3791/54018

Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, & Cheshier SH. (2016). Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. PloS one, 11(4), e0153550. https://doi.org/10.1371/journal.pone.0153550

Hutter G., Hofer S, Tzankov A, & Kothbauer KF. (2015). Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report. Neurosurgery, 77(6), E979–E983. https://doi.org/10.1227/neu.0000000000000925

Mitra SS, Feroze AH, Gholamin S, Richard C, Esparza R, Zhang M, Azad TD, Alrfaei B, Kahn SA, Hutter G, Guzman R, Creasey GH, Plant GW, Weissman IL, Edwards MS, & Cheshier S. (2015). Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells. Neurosurgery, 77(5), 794–802; discussion 802. https://doi.org/10.1227/neu.0000000000000918

Hutter,Gregor, Benz,Romedi, Taub,Ethan, Kothbauer,Karl F. , & Baur,Martin. (2014). Extensive cervical prevertebral haemorrhage with airway obstruction after low-energy hyperextension injury. Injury Extra, 45(8), 53–55. https://doi.org/10.1016/j.injury.2014.04.030

Cordier, Dominik, Gerber, Alexander, Kluba, Christiane, Bauman, Andreas, Hutter, Gregor, Mindt, Thomas L., & Mariani, Luigi. (2014). Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy. Cancer Biotherapy and Radiopharmaceuticals, 29(5), 221–226. https://doi.org/10.1089/cbr.2013.1588

Hutter G., von Felten S, Sailer MH, Schulz M., & Mariani L. (2014). Risk factors for postoperative CSF leakage after elective craniotomy and the efficacy of fleece-bound tissue sealing against dural suturing alone: A randomized controlled trial - Clinical article. Journal of Neurosurgery, 121(3), 735–744. https://doi.org/10.3171/2014.6.jns131917

Nuvolone M, Kana V, Hutter G, Sakata D, Mortin-Toth SM, Russo G, Danska JS, & Aguzzi A. (2013). SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells. The Journal of Experimental Medicine, 210(12), 2539–2552. https://doi.org/10.1084/jem.20131274

Leu, Severina, Von Felten, Stefanie, Frank, Stephan, Vassella, Erik, Vajtai, Istvan, Taylor, Elisabeth, Schulz, Marianne, Hutter, Gregor, Hench, Jurgen, Schucht, Philippe, Boulay, Jean-Louis, & Mariani, Luigi. (2013). IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival. Neuro-Oncology, 15, 469–479. https://doi.org/10.1093/neuonc/nos317

Sailer, Martin H M, Gerber, Alexandra, Tostado, Cristóbal, Hutter, Gregor, Cordier, Dominik, Mariani, Luigi, & Ritz, Marie-Françoise. (2013). Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling. Journal of Cell Science, 126(Pt 16), 3533–3540. https://doi.org/10.1242/jcs.125757

Kranich, Jan, Krautler, Nike Julia, Falsig, Jeppe, Ballmer, Boris, Li, Shulei, Hutter, Gregor, Schwarz, Petra, Moos, Rita, Julius, Christian, Miele, Gino, & Aguzzi, Adriano. (2010). Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner. JOURNAL OF EXPERIMENTAL MEDICINE, 207, 2271–2281. https://doi.org/10.1084/jem.20092401

Julius, C., Hutter, G., Wagner, U., Seeger, H., Kana, V., Kranich, J., Klöhn, P.-C., Weissmann, C., Miele, G., & Aguzzi, A. (2009). Corrigendum to “Transcriptional Stability of Cultured Cells upon Prion Infection” [J. Mol. Biol. 375 (2008) 1222-1233] (DOI:10.1016/j.jmb.2007.11.003). Journal of Molecular Biology, 388(1). https://doi.org/10.1016/j.jmb.2008.11.015

Chen D, Steele AD, Hutter G, Bruno J, Govindarajan A, Easlon E, Lin SJ, Aguzzi A, Lindquist S, & Guarente L. (2008). The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Experimental gerontology, 43(12), 1086–1093. https://doi.org/10.1016/j.exger.2008.08.050

Steele AD, Hutter G, Jackson WS, Heppner FL, Borkowski AW, King OD, Raymond GJ, Aguzzi A, & Lindquist S. (2008). Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease. Proceedings of the National Academy of Sciences of the United States of America, 105(36), 13626–13631. https://doi.org/10.1073/pnas.0806319105

Julius C, Hutter G, Wagner U, Seeger H, Kana V, Kranich J, Klöhn PC, Weissmann C, Miele G, & Aguzzi A. (2008). Transcriptional stability of cultured cells upon prion infection. Journal of molecular biology, 375(5), 1222–1233. https://doi.org/10.1016/j.jmb.2007.11.003

Ingold B, Moschopulos M, Hutter G, Seeger H, Röthlisberger B, Landolt H, Yonekawa Y, Jochum W, & Heppner FL. (2006). Abdominal seeding of an atypical teratoid/rhabdoid tumor of the pineal gland along a ventriculoperitoneal shunt catheter. (Patent No. 1). 111(1), Article 1. https://doi.org/10.1007/s00401-005-1112-7

Hutter G, Heppner FL, & Aguzzi A. (2003). No superoxide dismutase activity of cellular prion protein in vivo. Biological chemistry, 384(9), 1279–1285. https://doi.org/10.1515/bc.2003.142